Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
CONCLUSION: In this cohort of prostate SABR patients we estimate the OAR treatment DVH was higher than planned. This was due to rectal and bladder organ variation.
ADVANCES IN KNOWLEDGE: OAR variation in prostate SABR using a FFF technique, may cause the treatment DVH to be higher than planned.
PMID: 31971829 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Devlin L, Dodds D, Sadoyze A, McLoone P, MacLeod N, Lamb C, Smith S, Thomson S, Duffton A Tags: Br J Radiol Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | PET Scan | Prostate Cancer | Radiology | Statistics | Study | UK Health